Cefotaxime
- Molecular formula
- C16H17N5O7S2
- CAS Number
- 63527-52-6
- IUPAC Name
- 3-(acetoxymethyl)-7-[[2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Molecular Weight
- 477.51g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.7100g/cm3
Identification
Interesting Facts about 3-(Acetoxymethyl)-7-[[2-(2-Aminothiazol-4-yl)-2-Methoxyimino-Acetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate
This complex compound belongs to a fascinating class of molecules known for their biological activity. Often, compounds with such intricate designs are explored for their potential in pharmaceuticals, particularly in the development of antibiotics and anti-cancer agents.
Key Highlights
- Structural Diversity: The structure of this compound features unique bicyclic frameworks, which contribute to its potentially enhanced biological properties.
- Biological Relevance: Molecules containing thiazoles and oxo groups are often associated with improved activity against various pathogens. The presence of amino groups can also enhance their interaction with biological targets.
- Synthetic Pathways: The synthesis of such compounds is a great example of how organic chemistry can create complex molecules. Chemists often utilize various reaction conditions and reagents to construct these intricate structures.
As scientists continue to explore such compounds, they not only provide insight into fundamental chemistry principles but also pave the way for new medications and treatments. In the words of Dr. Marie Curie, "Nothing in life is to be feared, it is only to be understood." Understanding compounds like this can lead to groundbreaking advancements in therapeutic applications.
Overall, the study of 3-(acetoxymethyl)-7-[[2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate illustrates the impact of structural complexity on biological efficacy, showcasing a pivotal avenue in drug discovery.